Cyclin-dependent kinase inhibitors in restriction point control, genomic stability, and tumorigenesis

Journal of Cellular Biochemistry

Volumn , Issue SUPPL. 30/31, 1998, Pages 37-42

  Sean Millard, S ^a,b   Koff, Andrew ^a,b  

^a Weill Graduate School of Medical Sciences of Cornell University   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cell growth; Cyclin dependent kinases; Genomic stability; Restriction point control; Tumorigenesis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE; CYCLINE; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GROWTH REGULATION; KNOCKOUT GENE; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL DIVISION; DRUG ANTAGONISM; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS;

EID: 0032432556     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Agrawal D HP, McPherson F, Dong F, Garcia A, Pledger WJ (1996): Repression of p27Kip1 synthesis by platlet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 16:4327-4336.
2. Brugarolas J CC, Gordon JI, Beach D, Jacks T, Hannon GJ (1995): Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
3. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich V Jr, Chao MV, Koff A(1997): Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kipl. Genes Dev 11:2335-2346.
4. Coats S FW, Nourse J, Roberts JM (1996): Requirement of p27Kipl for restriction point control of the fibroblast cell cycle. Science 272:877-880.
5. Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI (1998): Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 90:1284-1291.
6. cp1/Wafl undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
7. Fero MIRM, Tasch M, Porter P, Carow CE Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM (1996): A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1-deficient mice. Cell 85:733-744.
8. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y (1998): CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12:2899-2911.
9. Hatada I, Mukai T (1995): Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11:204-206.
10. Hengst L, Reed SI (1996): Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861-1864.
11. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ (1997): Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649-659.
12. Kaplan MH, Daniel C, Schindler U, Grusby MJ (1998): Stat proteins control lymphocyte proliferation by regulating p27Kipl expression. Mol Cell Biol 18:1996-2003.
13. KiP1. Cell 85:721-732.
14. Levine A (1997): p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
15. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP (1996): Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153.